INSM INSMED Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: INSM

Price (delayed)

$24.8

Market cap

$3.68B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$5.34

Enterprise value

$4.56B

Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is a first-in-disease therapy approved ...

Highlights
The company's gross profit rose by 26% YoY and by 9% QoQ
INSM's revenue is up by 24% year-on-year and by 9% since the previous quarter
INSMED's net income has shrunk by 56% YoY and by 3.6% QoQ
The company's quick ratio fell by 41% YoY and by 13% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.insmed.com
Peers: SRPT GILD ALIM ARRY

Key stats

What are the main financial stats of INSM
Market
Shares outstanding
148.49M
Market cap
$3.68B
Enterprise value
$4.56B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
11.41
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.94
Earnings
Revenue
$305.21M
EBIT
-$665.32M
EBITDA
-$645.53M
Free cash flow
-$549.54M
Per share
EPS
-$5.34
Free cash flow per share
-$3.91
Book value per share
-$2.32
Revenue per share
$2.17
TBVPS
$8.05
Balance sheet
Total assets
$1.33B
Total liabilities
$1.66B
Debt
$1.36B
Equity
-$331.92M
Working capital
$703.43M
Liquidity
Debt to equity
-4.09
Current ratio
4.12
Quick ratio
3.64
Net debt/EBITDA
-1.36
Margins
EBITDA margin
-211.5%
Gross margin
78.5%
Net margin
-245.6%
Operating margin
-232.5%
Efficiency
Return on assets
-53.4%
Return on equity
N/A
Return on invested capital
-39%
Return on capital employed
-60.3%
Return on sales
-218%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

INSM stock price

How has the INSMED stock price performed over time
Intraday
-0.48%
1 week
1.97%
1 month
-8.22%
1 year
28.1%
YTD
-19.97%
QTD
-8.59%

Financial performance

How have INSMED's revenue and profit performed over time
Revenue
$305.21M
Gross profit
$239.64M
Operating income
-$709.63M
Net income
-$749.57M
Gross margin
78.5%
Net margin
-245.6%
INSMED's net income has shrunk by 56% YoY and by 3.6% QoQ
INSMED's operating income has shrunk by 55% YoY and by 3.9% QoQ
The company's gross profit rose by 26% YoY and by 9% QoQ
INSMED's operating margin has decreased by 25% YoY but it has increased by 4.4% from the previous quarter

Growth

What is INSMED's growth rate over time

Valuation

What is INSMED stock price valuation
P/E
N/A
P/B
N/A
P/S
11.41
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.94
The EPS has declined by 37% year-on-year
The equity is down by 15% from the previous quarter
INSM's price to sales (P/S) is 26% lower than its 5-year quarterly average of 15.5 and 2.5% lower than its last 4 quarters average of 11.7
INSM's revenue is up by 24% year-on-year and by 9% since the previous quarter

Efficiency

How efficient is INSMED business performance
The company's return on assets fell by 35% YoY and by 10% QoQ
The ROS has declined by 18% year-on-year but it has grown by 5% since the previous quarter
The ROIC has declined by 4.6% year-on-year

Dividends

What is INSM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INSM.

Financial health

How did INSMED financials performed over time
INSM's total assets is 20% lower than its total liabilities
The company's quick ratio fell by 41% YoY and by 13% QoQ
The current ratio has contracted by 38% YoY and by 13% from the previous quarter
The debt to equity has plunged by 127% YoY but it is up by 12% from the previous quarter
The equity is down by 15% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.